No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d4kv5A_, 1.0000, 0.00, 1.000, 112, 112, SCFV GC1009 IN COMPLEX WITH TGF-BETA1.
2, d4kv5C_, 0.9949, 0.28, 1.000, 112, 112, SCFV GC1009 IN COMPLEX WITH TGF-BETA1.
3, d4kv5B_, 0.9923, 0.34, 1.000, 112, 112, SCFV GC1009 IN COMPLEX WITH TGF-BETA1.
4, d4kv5D_, 0.9903, 0.39, 1.000, 112, 112, SCFV GC1009 IN COMPLEX WITH TGF-BETA1.
5, d3kfdB_, 0.9707, 0.70, 1.000, 112, 112, TERNARY COMPLEX OF TGF-B1 REVEALS ISOFORM-SPECIFIC LIGAND RECOGNITION AND RECEPTOR RECRUITMENT IN THE SUPERFAMILY
6, d3kfdD_, 0.9704, 0.71, 1.000, 112, 112, TERNARY COMPLEX OF TGF-B1 REVEALS ISOFORM-SPECIFIC LIGAND RECOGNITION AND RECEPTOR RECRUITMENT IN THE SUPERFAMILY
7, d3eo1I_, 0.9626, 0.82, 0.768, 112, 112, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
8, d3eo1C_, 0.9626, 0.82, 0.768, 112, 112, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
9, d3kfdC_, 0.9606, 0.81, 1.000, 112, 112, TERNARY COMPLEX OF TGF-B1 REVEALS ISOFORM-SPECIFIC LIGAND RECOGNITION AND RECEPTOR RECRUITMENT IN THE SUPERFAMILY
10, d3kfdA_, 0.9606, 0.81, 1.000, 112, 112, TERNARY COMPLEX OF TGF-B1 REVEALS ISOFORM-SPECIFIC LIGAND RECOGNITION AND RECEPTOR RECRUITMENT IN THE SUPERFAMILY
11, d2pjyA_, 0.9600, 0.84, 0.768, 112, 112, STRUCTURAL BASIS FOR COOPERATIVE ASSEMBLY OF THE TGF-BETA SIGNALING COMPLEX
12, d3eo1L_, 0.9595, 0.89, 0.768, 112, 112, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
13, d3eo1F_, 0.9595, 0.89, 0.768, 112, 112, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
14, d4kxzE_, 0.9576, 0.89, 0.714, 112, 112, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
15, d4kxzA_, 0.9549, 0.92, 0.714, 112, 112, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
16, d4kxzD_, 0.9526, 0.94, 0.714, 112, 112, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
17, d1tgkA_, 0.9520, 0.93, 0.768, 112, 112, HUMAN TRANSFORMING GROWTH FACTOR BETA 3 CRYSTALLIZED FROM PEG 4000
18, d1tgjA_, 0.9513, 0.95, 0.768, 112, 112, HUMAN TRANSFORMING GROWTH FACTOR-BETA 3 CRYSTALLIZED FROM DIOXANE
19, d4kxzB_, 0.9479, 1.00, 0.714, 112, 112, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
20, d1tfgA_, 0.8743, 1.66, 0.714, 112, 112, AN UNUSUAL FEATURE REVEALED BY THE CRYSTAL STRUCTURE AT 2.2 ANGSTROMS RESOLUTION OF HUMAN TRANSFORMING GROWTH FACTOR-BETA2
21, d2tgiA_, 0.8724, 1.69, 0.714, 112, 112, CRYSTAL STRUCTURE OF TRANSFORMING GROWTH FACTOR-BETA2: AN UNUSUAL FOLD FOR THE SUPERFAMILY
22, d1klcB_, 0.8615, 1.60, 0.991, 112, 111, SOLUTION STRUCTURE OF TGF-B1 NMR MINIMIZED AVERAGE STRUCTURE
23, d1klcA_, 0.8615, 1.60, 0.991, 112, 111, SOLUTION STRUCTURE OF TGF-B1 NMR MINIMIZED AVERAGE STRUCTURE
24, d1klaA_, 0.8608, 1.64, 0.991, 112, 111, SOLUTION STRUCTURE OF TGF-B1 NMR MODELS 1-17 OF 33 STRUCTURES
25, d1klaB_, 0.8607, 1.64, 0.991, 112, 111, SOLUTION STRUCTURE OF TGF-B1 NMR MODELS 1-17 OF 33 STRUCTURES
26, d1kldB_, 0.8103, 2.05, 0.973, 112, 111, SOLUTION STRUCTURE OF TGF-B1 NMR MODELS 18-33 OF 33 STRUCTURES
27, d1kldA_, 0.8103, 2.05, 0.973, 112, 111, SOLUTION STRUCTURE OF TGF-B1 NMR MODELS 18-33 OF 33 STRUCTURES
28, d5tx2A_, 0.7798, 1.10, 0.674, 92, 92, MINIATURE TGF-BETA2 3-MUTANT MONOMER
29, d5tx4B_, 0.7776, 1.08, 0.761, 92, 92, DERIVATIVE OF MOUSE TGF-BETA2 WITH A DELETION OF RESIDUES 52-71 AND K25R R26K L51R A74K C77S L89V I92V K94R T95K I98V SINGLE AMINO ACID SUBSTITUTIONS BOUND TO HUMAN TGF-BETA TYPE II RECEPTOR ECTODOMAIN RESIDUES 15-130
30, d2qcwB_, 0.7740, 1.68, 0.347, 104, 98, CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-6 (BMP-6)
31, d5tx6B_, 0.7736, 1.15, 0.761, 92, 92, STRUCTURE OF TGF-BETA2 DERIVATIVE WITH DELETION OF RESIDUES 52-71 AND 10 SINGLE AMINO ACID MUTATIONS (MMTGF-BETA2-7M)
32, d5tx2B_, 0.7733, 1.18, 0.685, 92, 92, MINIATURE TGF-BETA2 3-MUTANT MONOMER
33, d2r53A_, 0.7726, 2.02, 0.350, 107, 100, CRYSTAL STRUCTURE ANALYSIS OF BONE MORPHOGENETIC PROTEIN-6 VARIANT B2 (B2-BMP-6)
34, d4ui2B_, 0.7725, 1.89, 0.343, 104, 99, CRYSTAL STRUCTURE OF THE TERNARY RGMB-BMP2-NEO1 COMPLEX
35, d2r52A_, 0.7718, 1.82, 0.354, 105, 99, CRYSTAL STRUCTURE ANALYSIS OF BONE MORPHOGENETIC PROTEIN-6 (BMP-6)
36, d4uhzA_, 0.7694, 1.91, 0.343, 104, 99, CRYSTAL STRUCTURE OF THE HUMAN RGMB-BMP2 COMPLEX CRYSTAL FORM 1
37, d2h62B_, 0.7689, 1.72, 0.347, 103, 98, CRYSTAL STRUCTURE OF A TERNARY LIGAND-RECEPTOR COMPLEX OF BMP-2
38, d3qb4C_, 0.7670, 2.16, 0.300, 106, 100, CRYSTAL STRUCTURE OF A TGF-BETA LIGAND-RECEPTOR COMPLEX
39, p4faoH_, 0.7666, 2.16, 0.300, 106, 100, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
40, p4faoh_, 0.7662, 1.91, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
41, p4faog_, 0.7661, 1.92, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
42, p4faoG_, 0.7657, 1.93, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
43, p4faoS_, 0.7656, 1.93, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
44, p4faoa_, 0.7654, 1.92, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
45, p4faoT_, 0.7650, 1.93, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
46, p4faob_, 0.7650, 1.94, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
47, p4faoM_, 0.7648, 1.93, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
48, p4faoA_, 0.7644, 1.93, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
49, p4faoB_, 0.7643, 1.92, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
50, d4ui0B_, 0.7624, 1.94, 0.303, 105, 99, CRYSTAL STRUCTURE OF THE HUMAN RGMB-BMP2 COMPLEX CRYSTAL FORM 2
51, d2bhkA_, 0.7617, 1.98, 0.343, 104, 99, CRYSTAL STRUCTURE OF HUMAN GROWTH AND DIFFERENTIATION FACTOR 5 (GDF5)
52, d5tx6A_, 0.7607, 2.10, 0.283, 105, 99, STRUCTURE OF TGF-BETA2 DERIVATIVE WITH DELETION OF RESIDUES 52-71 AND 10 SINGLE AMINO ACID MUTATIONS (MMTGF-BETA2-7M)
53, d1waqA_, 0.7607, 0.72, 0.784, 88, 88, CRYSTAL STRUCTURE OF HUMAN GROWTH AND DIFFERENTIATION FACTOR 5 (GDF-5)
54, p4uhyB_, 0.7605, 1.92, 0.286, 104, 98, CRYSTAL STRUCTURE OF THE HUMAN RGMA-BMP2 COMPLEX
55, d4n1dA_, 0.7571, 2.01, 0.343, 105, 99, NODAL/BMP2 CHIMERA NB250
56, d4ui1A_, 0.7568, 2.19, 0.310, 105, 100, CRYSTAL STRUCTURE OF THE HUMAN RGMC-BMP2 COMPLEX
57, p4faoN_, 0.7565, 2.09, 0.343, 104, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
58, d4ui0A_, 0.7562, 1.94, 0.306, 104, 98, CRYSTAL STRUCTURE OF THE HUMAN RGMB-BMP2 COMPLEX CRYSTAL FORM 2
59, p4uhyA_, 0.7549, 2.05, 0.343, 101, 99, CRYSTAL STRUCTURE OF THE HUMAN RGMA-BMP2 COMPLEX
60, d4ui1B_, 0.7536, 2.05, 0.343, 104, 99, CRYSTAL STRUCTURE OF THE HUMAN RGMC-BMP2 COMPLEX
61, d2qcqA_, 0.7534, 2.13, 0.343, 105, 99, CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-3 (BMP-3)
62, d5hk5B_, 0.7522, 2.35, 0.293, 107, 99, STRUCTURE OF THE GREM2-GDF5 INHIBITORY COMPLEX
63, d2qcqB_, 0.7521, 2.16, 0.303, 105, 99, CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-3 (BMP-3)
64, d5hk5A_, 0.7516, 2.18, 0.296, 108, 98, STRUCTURE OF THE GREM2-GDF5 INHIBITORY COMPLEX
65, d2h64A1, 0.7514, 2.18, 0.296, 108, 98, CRYSTAL STRUCTURE OF A TERNARY LIGAND-RECEPTOR COMPLEX OF BMP-2
66, d1bmpA_, 0.7512, 2.17, 0.303, 105, 99, BONE MORPHOGENETIC PROTEIN-7
67, d5hk5C_, 0.7497, 2.36, 0.340, 105, 100, STRUCTURE OF THE GREM2-GDF5 INHIBITORY COMPLEX
68, d5hk5D_, 0.7495, 2.05, 0.337, 104, 98, STRUCTURE OF THE GREM2-GDF5 INHIBITORY COMPLEX
69, d3evsB_, 0.7473, 2.19, 0.303, 105, 99, CRYSTAL STRUCTURE OF THE GDF-5:BMP RECEPTOR IB COMPLEX.
70, d1lxiA_, 0.7450, 2.19, 0.303, 105, 99, REFINEMENT OF BMP7 CRYSTAL STRUCTURE
71, d1reuA_, 0.7437, 1.99, 0.299, 104, 97, STRUCTURE OF THE BONE MORPHOGENETIC PROTEIN 2 MUTANT L51P
72, d3qb4A_, 0.7421, 2.15, 0.337, 104, 98, CRYSTAL STRUCTURE OF A TGF-BETA LIGAND-RECEPTOR COMPLEX
73, d1lx5A_, 0.7379, 2.26, 0.347, 103, 98, CRYSTAL STRUCTURE OF THE BMP7/ACTRII EXTRACELLULAR DOMAIN COMPLEX
74, d3hh2A_, 0.7377, 2.28, 0.303, 105, 99, CRYSTAL STRUCTURE OF THE MYOSTATIN:FOLLISTATIN 288 COMPLEX
75, d3hh2B_, 0.7370, 2.22, 0.327, 104, 98, CRYSTAL STRUCTURE OF THE MYOSTATIN:FOLLISTATIN 288 COMPLEX
76, d5vt2B_, 0.7367, 2.81, 0.317, 109, 101, CRYSTAL STRUCTURE OF GROWTH DIFFERENTIATION FACTOR
77, d2gooD_, 0.7363, 2.82, 0.317, 109, 101, TERNARY COMPLEX OF BMP-2 BOUND TO BMPR-IA-ECD AND ACTRII-ECD
78, d2b0uA_, 0.7352, 2.16, 0.200, 108, 100, THE STRUCTURE OF THE FOLLISTATIN:ACTIVIN COMPLEX
79, d3b4vB_, 0.7335, 2.33, 0.343, 104, 99, X-RAY STRUCTURE OF ACTIVIN IN COMPLEX WITH FSTL3
80, d5i05A_, 0.7331, 2.78, 0.363, 116, 102, CRYSTAL STRUCTURE OF HUMAN BMP9 AT 1.87 A RESOLUTION
81, d1zkzA_, 0.7329, 2.35, 0.367, 114, 98, CRYSTAL STRUCTURE OF BMP9
82, d2qjbB_, 0.7323, 2.34, 0.267, 107, 101, CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT IA/IB
83, d2r52B_, 0.7320, 2.22, 0.270, 107, 100, CRYSTAL STRUCTURE ANALYSIS OF BONE MORPHOGENETIC PROTEIN-6 (BMP-6)
84, d2b0uB_, 0.7319, 2.46, 0.343, 104, 99, THE STRUCTURE OF THE FOLLISTATIN:ACTIVIN COMPLEX
85, d2p6aB1, 0.7318, 2.29, 0.343, 105, 99, THE STRUCTURE OF THE ACTIVIN:FOLLISTATIN 315 COMPLEX
86, d3bmpA_, 0.7300, 2.71, 0.360, 116, 100, HUMAN BONE MORPHOGENETIC PROTEIN-2 (BMP-2)
87, d1es7A_, 0.7296, 2.77, 0.350, 116, 103, COMPLEX BETWEEN BMP-2 AND TWO BMP RECEPTOR IA ECTODOMAINS
88, d2gooA_, 0.7294, 2.53, 0.343, 106, 99, TERNARY COMPLEX OF BMP-2 BOUND TO BMPR-IA-ECD AND ACTRII-ECD
89, d2qjaB_, 0.7291, 2.42, 0.343, 104, 99, CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT B12
90, d1es7C_, 0.7290, 2.33, 0.347, 103, 98, COMPLEX BETWEEN BMP-2 AND TWO BMP RECEPTOR IA ECTODOMAINS
91, d2bmpA_, 0.7282, 2.63, 0.343, 104, 99,  
92, p5vqfC2, 0.7272, 2.43, 0.343, 104, 99, CRYSTAL STRUCTURE OF PRO-TGF-BETA 1
93, d3b4vF_, 0.7272, 2.55, 0.343, 105, 99, X-RAY STRUCTURE OF ACTIVIN IN COMPLEX WITH FSTL3
94, d1rewA_, 0.7268, 2.41, 0.890, 126, 100, STRUCTURAL REFINEMENT OF THE COMPLEX OF BONE MORPHOGENETIC PROTEIN 2 AND ITS TYPE IA RECEPTOR
95, d2qcwA_, 0.7262, 2.34, 0.381, 114, 97, CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-6 (BMP-6)
96, d5vt2A_, 0.7253, 2.28, 0.347, 103, 98, CRYSTAL STRUCTURE OF GROWTH DIFFERENTIATION FACTOR
97, d3bk3B_, 0.7250, 2.23, 0.357, 104, 98, CRYSTAL STRUCTURE OF THE COMPLEX OF BMP-2 AND THE FIRST VON WILLEBRAND DOMAIN TYPE C OF CROSSVEINLESS-2
98, p4ycgD_, 0.7249, 2.42, 0.158, 108, 101, PRO-BONE MORPHOGENETIC PROTEIN 9
99, d2p6aA1, 0.7248, 2.42, 0.158, 108, 101, THE STRUCTURE OF THE ACTIVIN:FOLLISTATIN 315 COMPLEX
100, d2qj9B_, 0.7244, 2.45, 0.327, 104, 98, CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT B1
101, d1rewB_, 0.7244, 2.49, 0.283, 106, 99, STRUCTURAL REFINEMENT OF THE COMPLEX OF BONE MORPHOGENETIC PROTEIN 2 AND ITS TYPE IA RECEPTOR
102, p5vqfA2, 0.7237, 2.68, 0.356, 116, 101, CRYSTAL STRUCTURE OF PRO-TGF-BETA 1
103, d2qjaA_, 0.7215, 2.52, 0.347, 103, 98, CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT B12
104, d2h62A_, 0.7215, 2.16, 0.351, 103, 97, CRYSTAL STRUCTURE OF A TERNARY LIGAND-RECEPTOR COMPLEX OF BMP-2
105, p4yciD_, 0.7214, 2.40, 0.890, 132, 100, NON-LATENT PRO-BONE MORPHOGENETIC PROTEIN 9
106, p4ycgC_, 0.7214, 2.54, 0.337, 104, 98, PRO-BONE MORPHOGENETIC PROTEIN 9
107, p4yciC_, 0.7212, 2.57, 0.343, 104, 99, NON-LATENT PRO-BONE MORPHOGENETIC PROTEIN 9
108, d2r53B_, 0.7212, 2.42, 0.286, 105, 98, CRYSTAL STRUCTURE ANALYSIS OF BONE MORPHOGENETIC PROTEIN-6 VARIANT B2 (B2-BMP-6)
109, d5jhwA_, 0.7204, 2.51, 0.283, 106, 99, CRYSTAL STRUCTURE OF THE GDF11:FOLLISTATIN 288 COMPLEX
110, d5e4gA_, 0.7202, 2.39, 0.286, 105, 98, CRYSTAL STRUCTURE OF HUMAN GROWTH DIFFERENTIATION FACTOR 11 (GDF-11)
111, p3rjrC2, 0.7196, 2.52, 0.350, 107, 100, CRYSTAL STRUCTURE OF PRO-TGF BETA 1
112, p3rjrA2, 0.7193, 3.00, 0.324, 109, 102, CRYSTAL STRUCTURE OF PRO-TGF BETA 1
113, d1m4uL_, 0.7193, 2.94, 0.320, 108, 103, CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-7 (BMP-7) IN COMPLEX WITH THE SECRETED ANTAGONIST NOGGIN
114, d4midA_, 0.7186, 2.45, 0.890, 126, 100, CRYSTAL STRUCTURE OF ACTIVIN A/BMP2 CHIMERA
115, d2qj9A_, 0.7182, 2.32, 0.899, 128, 99, CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT B1
116, d3bk3A_, 0.7172, 2.51, 0.330, 112, 97, CRYSTAL STRUCTURE OF THE COMPLEX OF BMP-2 AND THE FIRST VON WILLEBRAND DOMAIN TYPE C OF CROSSVEINLESS-2
117, d3b4vA_, 0.7167, 2.74, 0.333, 112, 99, X-RAY STRUCTURE OF ACTIVIN IN COMPLEX WITH FSTL3
118, d5vz3A_, 0.7164, 2.61, 0.384, 105, 99, GROWTH FACTOR CRYSTAL STRUCTURE AT 1.97 ANGSTROM RESOLUTION
119, d2qjbA_, 0.7158, 2.60, 0.343, 104, 99, CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT IA/IB
120, d4mplA_, 0.7157, 2.54, 0.327, 104, 98, CRYSTAL STRUCTURE OF BMP9 AT 1.90 ANGSTROM
121, d5jhwB_, 0.7150, 2.64, 0.357, 109, 98, CRYSTAL STRUCTURE OF THE GDF11:FOLLISTATIN 288 COMPLEX
122, p3rjrB2, 0.7141, 2.79, 0.157, 108, 102, CRYSTAL STRUCTURE OF PRO-TGF BETA 1
123, d5vz4A_, 0.7137, 2.55, 0.347, 103, 98, RECEPTOR-GROWTH FACTOR CRYSTAL STRUCTURE AT 2.20 ANGSTROM RESOLUTION
124, d3b4vE_, 0.7086, 2.53, 0.270, 107, 100, X-RAY STRUCTURE OF ACTIVIN IN COMPLEX WITH FSTL3
125, p3rjrD2, 0.7035, 3.01, 0.324, 109, 102, CRYSTAL STRUCTURE OF PRO-TGF BETA 1
126, d5tx6C_, 0.7011, 2.11, 0.907, 121, 97, STRUCTURE OF TGF-BETA2 DERIVATIVE WITH DELETION OF RESIDUES 52-71 AND 10 SINGLE AMINO ACID MUTATIONS (MMTGF-BETA2-7M)
127, d3sekB_, 0.6931, 2.60, 0.167, 108, 102, CRYSTAL STRUCTURE OF THE MYOSTATIN:FOLLISTATIN-LIKE 3 COMPLEX
128, p5ffoC1, 0.6906, 2.66, 0.361, 107, 97, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
129, d2arvA_, 0.6806, 2.20, 0.907, 133, 97, STRUCTURE OF HUMAN ACTIVIN A
130, p5vqfB2, 0.6798, 0.71, 0.802, 81, 81, CRYSTAL STRUCTURE OF PRO-TGF-BETA 1
131, p5vqfD2, 0.6783, 2.88, 0.313, 109, 99, CRYSTAL STRUCTURE OF PRO-TGF-BETA 1
132, d1ktzA_, 0.6776, 2.07, 0.957, 94, 93, CRYSTAL STRUCTURE OF THE HUMAN TGF-BETA TYPE II RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH TGF-BETA3
133, p5ffoG1, 0.6734, 2.81, 0.344, 116, 96, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
134, d2arvB_, 0.6721, 2.81, 0.344, 116, 96, STRUCTURE OF HUMAN ACTIVIN A
135, d5f3hK_, 0.6619, 2.24, 0.904, 110, 94, STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY
136, d5f3hJ_, 0.6536, 2.22, 0.894, 130, 94, STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY
137, d5f3bC_, 0.6512, 1.79, 0.780, 82, 82, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
138, p5vqpA1, 0.6467, 1.80, 1.000, 89, 88, CRYSTAL STRUCTURE OF HUMAN PRO-TGF-BETA1
139, d1s4yB_, 0.6447, 3.00, 0.361, 106, 97, CRYSTAL STRUCTURE OF THE ACTIVIN/ACTRIIB EXTRACELLULAR DOMAIN
140, d5f3hI_, 0.6444, 2.38, 0.330, 105, 91, STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY
141, p5ntuA1, 0.6374, 2.50, 0.319, 104, 91, CRYSTAL STRUCTURE OF HUMAN PRO-MYOSTATIN PRECURSOR AT 2.6 A RESOLUTION
142, p5uhmA_, 0.6372, 2.53, 0.333, 106, 90, APO-STRUCTURE OF MATURE GROWTH DIFFERENTIATION FACTOR 11
143, p5uhmB_, 0.6367, 2.67, 0.806, 94, 93, APO-STRUCTURE OF MATURE GROWTH DIFFERENTIATION FACTOR 11
144, d5f3hL_, 0.6343, 3.30, 0.387, 111, 93, STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY
145, d5f3bD_, 0.6255, 2.61, 0.319, 104, 91, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
146, p5ffoH1, 0.6250, 3.02, 0.312, 163, 93, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
147, d2arpA_, 0.6232, 3.02, 0.312, 163, 93, ACTIVIN A IN COMPLEX WITH FS12 FRAGMENT OF FOLLISTATIN
148, d1nysB_, 0.6232, 2.12, 0.354, 87, 82, CRYSTAL STRUCTURE OF ACTIVIN A BOUND TO THE ECD OF ACTRIIB P41
149, d1nyuB_, 0.6206, 2.04, 0.366, 87, 82, CRYSTAL STRUCTURE OF ACTIVIN A BOUND TO THE ECD OF ACTRIIB
150, p5ffoD1, 0.6184, 2.75, 0.319, 104, 91, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
151, d5ji1B_, 0.6103, 2.44, 0.337, 103, 86, CRYSTAL STRUCTURE OF GDF8
152, d5ji1A_, 0.6088, 2.32, 0.864, 142, 88, CRYSTAL STRUCTURE OF GDF8
153, p5ntuB1, 0.6037, 2.32, 0.864, 142, 88, CRYSTAL STRUCTURE OF HUMAN PRO-MYOSTATIN PRECURSOR AT 2.6 A RESOLUTION
154, d2askA_, 0.5797, 2.86, 0.398, 105, 88, STRUCTURE OF HUMAN ARTEMIN
155, d1s4yD_, 0.5774, 1.94, 0.427, 85, 82, CRYSTAL STRUCTURE OF THE ACTIVIN/ACTRIIB EXTRACELLULAR DOMAIN
156, d1agqD_, 0.5753, 2.10, 0.410, 86, 83, GLIAL CELL-DERIVED NEUROTROPHIC FACTOR FROM RAT
157, d1nysD_, 0.5713, 2.62, 0.875, 125, 88, CRYSTAL STRUCTURE OF ACTIVIN A BOUND TO THE ECD OF ACTRIIB P41
158, p5nxsA2, 0.5702, 2.55, 0.349, 92, 83, CRYSTAL STRUCTURE OF HUMAN PRO-MYOSTATIN PRECURSOR AT 4.2 A RESOLUTION WITH EXPERIMENTAL PHASES FROM SEMET LABELLING
159, d2gh0C1, 0.5640, 2.56, 0.329, 95, 85, GROWTH FACTOR/RECEPTOR COMPLEX
160, d1agqC_, 0.5589, 2.31, 0.358, 144, 81, GLIAL CELL-DERIVED NEUROTROPHIC FACTOR FROM RAT
161, p5ty4B_, 0.5579, 2.54, 0.179, 101, 84, MICROED STRUCTURE OF A COMPLEX BETWEEN MONOMERIC TGF-B AND ITS RECEPTOR TBRII AT 2.9 A RESOLUTION
162, d2v5eB_, 0.5539, 2.54, 0.179, 101, 84, THE STRUCTURE OF THE GDNF:CORECEPTOR COMPLEX: INSIGHTS INTO RET SIGNALLING AND HEPARIN BINDING.
163, d1agqA_, 0.5526, 3.29, 0.391, 96, 87, GLIAL CELL-DERIVED NEUROTROPHIC FACTOR FROM RAT
164, d2gh0D1, 0.5495, 2.75, 0.138, 95, 87, GROWTH FACTOR/RECEPTOR COMPLEX
165, d3fubD_, 0.5460, 1.83, 0.444, 75, 72, CRYSTAL STRUCTURE OF GDNF-GFRALPHA1 COMPLEX
166, p5mr5A_, 0.5427, 3.65, 0.375, 126, 88, LIGAND-RECEPTOR COMPLEX.
167, d2gyrD_, 0.5419, 2.62, 0.195, 98, 82, CRYSTAL STRUCTURE OF HUMAN ARTEMIN
168, p5mr9A_, 0.5412, 2.76, 0.143, 91, 84, LIGAND-RECEPTOR COMPLEX.
169, d2gyzA_, 0.5412, 0.80, 0.892, 65, 65, CRYSTAL STRUCTURE OF HUMAN ARTEMIN
170, p5mr5B_, 0.5403, 3.43, 0.138, 101, 94, LIGAND-RECEPTOR COMPLEX.
171, d2gyrB_, 0.5381, 3.07, 0.138, 91, 87, CRYSTAL STRUCTURE OF HUMAN ARTEMIN
172, d2gyrE_, 0.5378, 2.71, 0.200, 98, 80, CRYSTAL STRUCTURE OF HUMAN ARTEMIN
173, d1m4uA_, 0.5370, 3.33, 0.099, 103, 91, CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-7 (BMP-7) IN COMPLEX WITH THE SECRETED ANTAGONIST NOGGIN
174, d3fubB_, 0.5360, 3.33, 0.099, 103, 91, CRYSTAL STRUCTURE OF GDNF-GFRALPHA1 COMPLEX
175, p5mr9B_, 0.5353, 3.22, 0.193, 98, 83, LIGAND-RECEPTOR COMPLEX.
176, d2gyrF_, 0.5348, 2.85, 0.195, 97, 82, CRYSTAL STRUCTURE OF HUMAN ARTEMIN
177, d2gyrC_, 0.5319, 3.26, 0.205, 99, 83, CRYSTAL STRUCTURE OF HUMAN ARTEMIN
178, d2gyrA_, 0.5297, 2.87, 0.195, 97, 82, CRYSTAL STRUCTURE OF HUMAN ARTEMIN
179, p5nmzD_, 0.5284, 3.28, 0.193, 98, 83, HUMAN NEURTURIN (97-197)
180, p5nxsB1, 0.5279, 2.80, 0.198, 97, 81, CRYSTAL STRUCTURE OF HUMAN PRO-MYOSTATIN PRECURSOR AT 4.2 A RESOLUTION WITH EXPERIMENTAL PHASES FROM SEMET LABELLING
181, p5nmzB_, 0.5257, 2.72, 0.200, 97, 80, HUMAN NEURTURIN (97-197)
182, d1agqB_, 0.5254, 2.54, 0.203, 199, 74, GLIAL CELL-DERIVED NEUROTROPHIC FACTOR FROM RAT
183, p5mr4B_, 0.5240, 2.54, 0.203, 199, 74, LIGAND-RECEPTOR COMPLEX.
184, p5hlzB_, 0.5229, 3.15, 0.143, 92, 84, STRUCTURE OF PRO-ACTIVIN A COMPLEX AT 2.85 A RESOLUTION
185, p5mr4A_, 0.5218, 3.28, 0.195, 101, 82, LIGAND-RECEPTOR COMPLEX.
186, p5hlzF_, 0.5200, 3.28, 0.195, 101, 82, STRUCTURE OF PRO-ACTIVIN A COMPLEX AT 2.85 A RESOLUTION
187, p5nmzC_, 0.5181, 3.00, 0.195, 97, 82, HUMAN NEURTURIN (97-197)
188, p5hzwB1, 0.5172, 2.76, 0.200, 97, 80, CRYSTAL STRUCTURE OF THE ORPHAN REGION OF HUMAN ENDOGLIN/CD105 IN COMPLEX WITH BMP9
189, p5nmzA_, 0.5166, 2.83, 0.200, 97, 80, HUMAN NEURTURIN (97-197)
190, p4ux8F_, 0.5159, 3.37, 0.207, 99, 82, RET RECOGNITION OF GDNF-GFRALPHA1 LIGAND BY A COMPOSITE BINDING SITE PROMOTES MEMBRANE-PROXIMAL SELF-ASSOCIATION
191, p4ux8D_, 0.5159, 2.79, 0.400, 135, 75, RET RECOGNITION OF GDNF-GFRALPHA1 LIGAND BY A COMPOSITE BINDING SITE PROMOTES MEMBRANE-PROXIMAL SELF-ASSOCIATION
192, p5hlyA2, 0.5158, 3.51, 0.205, 99, 83, STRUCTURE OF PRO-ACTIVIN A PRECURSOR AT 2.3 A RESOLUTION
193, p5hlzH_, 0.5131, 3.46, 0.154, 96, 91, STRUCTURE OF PRO-ACTIVIN A COMPLEX AT 2.85 A RESOLUTION
194, d2askB_, 0.5108, 3.39, 0.195, 98, 82, STRUCTURE OF HUMAN ARTEMIN
195, p5hlzD_, 0.5036, 3.33, 0.378, 86, 82, STRUCTURE OF PRO-ACTIVIN A COMPLEX AT 2.85 A RESOLUTION
196, p5hk5E_, 0.5030, 3.33, 0.210, 98, 81, STRUCTURE OF THE GREM2-GDF5 INHIBITORY COMPLEX
197, p5bpuB_, 0.5026, 3.37, 0.378, 86, 82, CRYSTAL STRUCTURE OF NORRIN A WNT SIGNALLING ACTIVATOR CRYSTAL FORM 2 I
198, p5hk5G_, 0.5022, 3.22, 0.200, 101, 80, STRUCTURE OF THE GREM2-GDF5 INHIBITORY COMPLEX
199, p5bqeA_, 0.5015, 1.72, 0.364, 70, 66, CRYSTAL STRUCTURE OF NORRIN IN COMPLEX WITH THE CYSTEINE-RICH DOMAIN OF FRIZZLED 4 -METHYLATED FORM
200, p5hk5F_, 0.5006, 3.36, 0.198, 101, 81, STRUCTURE OF THE GREM2-GDF5 INHIBITORY COMPLEX
